# Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

> **NCT01164150** · PHASE2 · TERMINATED · sponsor: **Cancer Trials Ireland** · enrollment: 92 (actual)

## Conditions studied

- Endometrial Cancer
- Gastrointestinal Complications
- Radiation Toxicity
- Urinary Complications

## Interventions

- **RADIATION:** 45 Gy/25 fractions

## Key facts

- **NCT ID:** NCT01164150
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164150, "Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01164150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*